During the past decade, Hospital Universitario Príncipe de Asturias conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 17 clinical trials were completed, i.e. on average, 29.3% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 12 clinical trials were completed. i.e. 41.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Príncipe de Asturias" #1 sponsor was "Fundacion SEIMC-GESIDA" with 9 trials, followed by "PETHEMA Foundation" with 7 trials sponsored, "Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias" with 5 trials sponsored, "Allergan" with 3 trials sponsored and "Bayer" with 3 trials sponsored. Other sponsors include 73 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Príncipe de Asturias" #1 collaborator was "ViiV Healthcare" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Hospital Universitario Principe de Asturias" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia" with 2 trials as a collaborator. Other collaborators include 61 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Príncipe de Asturias" are "HIV Infections" (8 trials), "COVID-19" (5 trials), "Diabetes Mellitus" (3 trials), "Gastroparesis" (3 trials) and "HIV Infection" (3 trials). Many other conditions were trialed in "Hospital Universitario Príncipe de Asturias" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Príncipe de Asturias" are "Drug" (61 trials), "Other" (13 trials), "Biological" (10 trials), "Procedure" (7 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Dexamethasone" (3 trials), "Acupuncture" (2 trials), "Cytarabine" (2 trials) and "Degarelix" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Príncipe de Asturias" are 96 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Príncipe de Asturias". 1 are not yet recruiting, 14 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in Hospital Universitario Príncipe de Asturias, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Príncipe de Asturias, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 5 trials that are defined as “Not Applicable".

Hospital Universitario Príncipe de Asturias has several departments that took part in Clinical trials: "Hospital Universitario Principe de Asturias; Servicio de Hematología" - 2 trials